Liu, Chao
Zhang, Yi-shu
Chen, Fang
Wu, Xiao-ying
Zhang, Bei-bei
Wu, Zhong-dao
Lei, Jun-xia
Funding for this research was provided by:
Double First-Class” university project grant from South China University of Technology of China (D6191800)
Open project of Key Laboratory of Tropical Disease Control (2019kfkt03)
Article History
Received: 13 December 2019
Revised: 2 May 2020
Accepted: 18 May 2020
First Online: 5 June 2020
Ethics approval and consent to participate
: All animal experiments were approved by the Medical Research Ethics Committee of Sun Yat-sen University and conformed to the Chinese National Institute of Health Guide for the Care and Use of Laboratory Animals (No. 2012-0081).
: Not applicable
: The South China University of Technology and Sun Yat-sen University have co-filed patent (201910854245.3) on the MSC-based cell therapy for the treatment of schistosomiasis, and Lei JX and Wu Zd are listed as co-inventors. The other authors declare that they have no competing interests.